PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Cy7 anti-mouse CD93 (AA4.1, early B lineage), 100 μg
PE/Cy7 anti-mouse CD93 (AA4.1, early B lineage), 25 μg
PE/Cy7 anti-mouse CD94, 200 μg
PE/Cy7 anti-mouse CD94, 50 μg
PE/Cy7 anti-mouse CX3CR1, 100 μg
PE/Cy7 anti-mouse CX3CR1, 25 μg
PE/Cy7 anti-mouse F4/80, 100 μg
PE/Cy7 anti-mouse F4/80, 25 μg
PE/Cy7 anti-mouse FcεRIα, 100 μg
PE/Cy7 anti-mouse FcεRIα, 25 μg
PE/Cy7 anti-mouse FR4 (Folate Receptor 4), 100 μg
PE/Cy7 anti-mouse H-2Db, 100 μg
PE/Cy7 anti-mouse H-2Db, 25 μg
PE/Cy7 anti-mouse H-2Kb bound to SIINFEKL, 100 μg
PE/Cy7 anti-mouse H-2Kb bound to SIINFEKL, 25 μg
PE/Cy7 anti-mouse H-2Kd, 100 μg